Download Preininger MK, Jha R, Maxwell JT, Wu Q, Singh M, Wang B, Dalal A, Mceachin ZT, Rossoll W, Hales CM, Fischbach PS, Wagner MB, Xu C. Dis Model Mech, 2016 Related Resources Patient specific Long QT syndrome type 3 cardiomyocytes can be used for clinical drug safety assessments Inter-individual differences in electrophysiology, pharmacology and drug responses in a cohort of hiPSC-derived cardiomyocytes: Endorsing clinical trials-in-a-dish Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization Sex-related differences in drug-induced QT prolongation and Torsades de Pointes: a new model system with human iPSC-CMs Related Products Image Cardiac Module